Viewing Study NCT02744768


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-01-19 @ 1:29 AM
Study NCT ID: NCT02744768
Status: UNKNOWN
Last Update Posted: 2018-03-22
First Post: 2016-04-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Sponsor:
Organization: